Cargando…

Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review

BACKGROUND: Accumulating evidence indicates inherited risk in the aetiology of lung cancer, although smoking exposure is the major attributing factor. Family history is a simple substitute for inherited susceptibility. Previous studies have shown some possible yet conflicting links between family hi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yue I., Gan, Yun Cui, Liu, Dan, Davies, Michael P. A., Li, Wei Min, Field, John K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842246/ https://www.ncbi.nlm.nih.gov/pubmed/31703574 http://dx.doi.org/10.1186/s12885-019-6317-6

Ejemplares similares

Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR Mutation
por: Schaller, Alexandre, et al.
Publicado: (2014)

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
por: Ahn, Jin Woo, et al.
Publicado: (2014)

Transcriptional Profiling of Non-Small Cell Lung Cancer Cells with Activating EGFR Somatic Mutations
por: Choi, Kuicheon, et al.
Publicado: (2007)

A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer
por: Cui, Ran, et al.
Publicado: (2022)

Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine
por: Lamy, Pierre-Jean, et al.
Publicado: (2012)

Potential of combination therapy in EGFR mutated lung cancer
por: Maemondo, Makoto
Publicado: (2020)

A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review
por: Li, Dan, et al.
Publicado: (2023)

Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden
por: Gabriel, Aurélie A G, et al.
Publicado: (2022)

EGFR Mutations and Lung Cancer
Publicado: (2005)

Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients
por: Buder, Anna, et al.
Publicado: (2021)

Mutational Analysis of EGFR and Related Signaling Pathway Genes in Lung Adenocarcinomas Identifies a Novel Somatic Kinase Domain Mutation in FGFR4
por: Marks, Jenifer L., et al.
Publicado: (2007)

Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio for EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated with First-Line EGFR-TKIs: A Large Population-Based Study and Literature Review
por: Gan, Yuncui, et al.
Publicado: (2022)

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts
por: Li, S, et al.
Publicado: (2014)

Association of EGFR mutations and HMGB1 genetic polymorphisms in lung adenocarcinoma patients
por: Wu, Yi-Liang, et al.
Publicado: (2019)

Characterization of Somatic Mutations in Air Pollution-Related Lung Cancer
por: Yu, Xian-Jun, et al.
Publicado: (2015)

Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
por: Wang, Fang, et al.
Publicado: (2019)

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21
por: Yu, Jiang-Yong, et al.
Publicado: (2016)

The Impact of Sequence of Chemotherapy and EGFR-TKI Treatment on Different EGFR Mutation Lung Adenocarcinoma
por: Chung, Fu-Tsai, et al.
Publicado: (2015)

Osimertinib or EGFR-TKIs/chemotherapy in patients with EGFR-mutated advanced nonsmall cell lung cancer: A meta-analysis
por: Huang, Lei, et al.
Publicado: (2019)

EGFR ‐plasma mutations in prognosis for non‐small cell lung cancer treated with EGFR TKIs: A meta‐analysis
por: Phan, Thang Thanh, et al.
Publicado: (2021)

Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
por: Thomas, Brian J., et al.
Publicado: (2023)

Somatic cell reprogramming-free generation of genetically modified pigs
por: Tanihara, Fuminori, et al.
Publicado: (2016)

Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature
por: Zhang, Shuangping, et al.
Publicado: (2021)

EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021)

KRAS and EGFR mutations coexisting in lung adenocarcinoma
por: Sousa, Vitor, et al.
Publicado: (2010)

EGFR unusual mutation status in lung adenocarcinomas
por: Alarcão, Ana, et al.
Publicado: (2010)

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)

Germline EGFR mutations in lung cancer (Review)
por: Liu, Minghui, et al.
Publicado: (2023)

Breast metastasis from EGFR‐mutated lung adenocarcinoma: A case report and review of the literature
por: Ota, Takayo, et al.
Publicado: (2018)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
por: Suda, Kenichi, et al.
Publicado: (2021)

EGFR mutation testing in blood for guiding EGFR tyrosine kinase inhibitor treatment in patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis
por: Yuan, Jin-Qiu, et al.
Publicado: (2017)

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
por: Smits, Alexander J. J., et al.
Publicado: (2012)

EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAF(V600E) mutation: a case report and review of literature
por: Zeng, Ran, et al.
Publicado: (2021)

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Yue-Lun, et al.
Publicado: (2016)

Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinoma
por: Peng, Jie, et al.
Publicado: (2020)

The Somatic Mutation Hit on Top of Genetic APC mutations Cause Skin Tumor()
por: Niu, Ting, et al.
Publicado: (2019)

Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
por: Kunimasa, Kei, et al.
Publicado: (2023)

Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma
por: Davies, Rhian Siân, et al.
Publicado: (2017)

Novel Somatic Genetic Variants as Predictors of Resistance to EGFR-Targeted Therapies in Metastatic Colorectal Cancer Patients
por: Riera, Pau, et al.
Publicado: (2020)

Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis
por: Ortiz, Andrés Felipe Herrera, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q2spcfgj716e5dd8rj2j5ahmed